FIELD: biotechnology.
SUBSTANCE: invention relates to a method for prediction of immunogenic modified peptides containing amino acid modifications, and can be used in medicine.
EFFECT: method for predicting immunogenic modified peptides can be used to create vaccines.
29 cl, 13 dwg, 8 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIBODIES USEFUL IN DIAGNOSING CANCER | 2018 |
|
RU2815883C1 |
VACCINE COMPOSITION FOR TREATMENT OF CANCER | 2018 |
|
RU2782261C2 |
INDIVIDUALIZED ANTI-TUMOR VACCINES | 2012 |
|
RU2779946C2 |
COMBINATION THERAPY USING ANTIBODIES AGAINST CLAUDIN 18.2 FOR CANCER TREATMENT | 2014 |
|
RU2792932C2 |
THERAPEUTIC RNA FOR OVARIAN CANCER | 2020 |
|
RU2832172C2 |
DIAGNOSTICS AND TREATMENT OF CANCER ASSOCIATED WITH CANCER STEM CELLS | 2014 |
|
RU2749867C2 |
THERAPY FOR TREATING CANCER, INCLUDING ANTIBODIES AGAINST CLAUDIN 18.2 | 2014 |
|
RU2832015C2 |
COMPOSITIONS OF VACCINES AGAINST NEOPLASIA AND METHODS FOR OBTAINING THEREOF | 2016 |
|
RU2753246C2 |
PERSONALIZED VACCINE | 2018 |
|
RU2779987C2 |
METHODS AND COMPOSITIONS FOR PREDICTION OF THERAPEUTIC EFFICIENCY OF TREATMENT OF ONCOLOGICAL DISEASES AND PREDICTION OF ONCOLOGICAL DISEASES | 2016 |
|
RU2785291C2 |
Authors
Dates
2020-06-23—Published
2014-05-07—Filed